剥离I-洋来揭开伪进展的奥秘
Erica S Tsang1, Lillian L Siu1
1Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Cancer cell
|September 12, 2023
概括
癌症进展后的 pembrolizumab 治疗在癌症患者中显示出混合的结果. 虽然有些人从瘤缩中受益,但其他人则经历了疾病的进展,需要仔细考虑治疗毒性.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 免疫治疗是一种免疫疗法.
背景情况:
- 布罗利祖马布是一种用于癌症治疗的免疫疗法药物.
- 治疗超出进展是患者的策略,尽管初始治疗,癌症恶化.
研究的目的:
- 分析pembrolizumab治疗在大量患者队列中超越进展的疗效和结果.
- 评估在接受长期 pembrolizumab 治疗的患者中瘤反应和进展的速度.
主要方法:
- 分析了来自6项临床试验的799名患者的数据.
- 在RECIST 1.1.所定义的进展标准之外,患者接受了 pembrolizumab.
- 通过测量瘤目标病变大小的变化来评估瘤反应.
主要成果:
- 在8.9%至24.4%的患者中观察到目标病变 (≥30%) 的显著减少.
- 相反,目标病变的大幅增加 (≥20%) 在11%至18%的患者中发生.
- 这些发现表明对延长布罗利祖马布治疗的异质反应.
结论:
- 继续使用布罗利祖马布的决定需要经过仔细评估.
- 必须权衡潜在的益处与与长期治疗相关的物理和财务毒性.
- 需要进一步的研究来优化这种治疗策略的患者选择.
更多相关视频
09:53Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
Published on: November 30, 2016
12.2K
05:23Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.1K
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
